🔗 Share this article

As America continues making sweeping changes to its immunization schedules, one figure has surfaced unexpectedly: Tracy Beth Høeg, a US-based sports physician and epidemiologist who first made her name by questioning Covid shots throughout the pandemic and has concentrated on possible fatalities following COVID-19 vaccination in her recent tenure at the Food and Drug Administration.

Planned Overhauls to Pediatric Vaccine Program

Health officials planned to announce sweeping revisions to the pediatric vaccination calendar in December, bringing the US with the Danish vaccine program, it is understood – a major change that would put the US out of step with many the world with insufficient data for benefit. This reveal has been postponed until the new year.

In place of the director of the vaccine center, Dr. Høeg is set to speak at the gathering. She was recently named temporary leader of the FDA’s drug evaluation center, the fifth appointee to lead the center this calendar year.

Consolidating Power at the Agency

This interim role could signify a strengthened alliance between the pharmaceutical and vaccine branches as Dr. Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it signals a greater focus upon dismantling already-approved immunizations at the FDA.

Dr. Høeg has often pushed for discontinuing some childhood immunization guidelines in the US in order to be more like Denmark's approach, a nation with universal health coverage and a population approximately the size of the state of Wisconsin.

So far public appearances, she has persisted in emphasizing on vaccines – typically the purview of Dr. Prasad, head of the FDA’s Center for Biologics Evaluation and Research (CBER) – as opposed to medication approval.

Doubts Over Background

Høeg has no apparent track record in pharmaceutical research, regulation or leadership, which has been standard for former leaders of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a top consultant to the FDA chief and the vaccine center since March.

“It seems she lacks to have the necessary background” for running the drug-regulation department, said Dr. Jonathan Howard. “She lacks experience running a randomized controlled trial. She lacks experience in running a major agency. She lacks background in pharmaceutical oversight.”

Past commissioners of the center would “be deeply familiar with legal statutes and the underlying principles of medication creation”, said a former acting FDA commissioner. “Frankly, she doesn’t have the sort of resume that previous people who ran the center have had.”

CDER has an immense workload at the agency, Woodcock emphasized.

“The public just zeroes in on the innovative therapies, but the generic program authorizes thousands of generic medications. There’s a biosimilars division, over-the-counter program and more, and each of these need to be managed,” she explained. “The responsibility you neglect, that is the part that I always told people is going to bite you.”

There is also, a substantial administrative component to the position, which oversees in excess of 5,000 personnel. “It is a huge management job, if you do it right,” Woodcock added.

Response and Disputed Policies

In response to questions about Dr. Høeg's fitness for the role and whether this appointment signifies more teamwork among agency officials on vaccines, a spokesperson said that the “inquiries are based on flawed premises”.

“This background is consistent with the duties of her role,” the official stated, pointing to the time Dr. Høeg spent guiding the FDA commissioner on “drug safety and oversight research, including predictive safety algorithms and vaccine surveillance”.

In her interim role, Dr. Høeg takes over the agency head's new fast-track approval initiative, a disputed expedited drug-approval program that allegedly troubled her former heads. “By what process are these therapies being picked for this fast-track system? Who makes the decisions?” Howard said. “There’s a lot of confidentiality happening at the FDA right now.”

In general, he remarked, “the FDA looks to be trending towards more relaxed oversight of all drugs, except for vaccines.”

Documented History on Immunizations

Regarding vaccines, Høeg has a more established, if problematic, past, Howard have noted. She published a research paper using non-validated public submissions to assess the frequency of heart inflammation following Covid vaccination. She advised the state of Florida chief medical officer Joseph Ladapo, who reportedly have modified findings to suggest COVID-19 vaccines are more dangerous than they are.

Included in her “wish list” for the incoming federal leadership encompassed revising regulations for recently developed shots and halting “unnecessary” vaccines, she remarked after the election on a online show. At the agency, Høeg has reportedly suggested preventing adolescent males from obtaining COVID-19 vaccinations.

“She’s an complete true believer who commences with her beliefs and reverse-engineers to retrofit the evidence in a extremely disingenuous, fraudulent way,” Howard stated.

Gaining Influence and a “Revenge Tour”

Høeg joined fellow skeptics, {like|